Difference between revisions of "Part:BBa K511200"

(Undo revision 119038 by Grantrob (Talk))
Line 4: Line 4:
 
This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants.
 
This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants.
  
https://static.igem.org/mediawiki/2011/5/50/CI434_Characterization.jpg
+
<img src='https://static.igem.org/mediawiki/2011/5/50/CI434_Characterization.jpg' style="width:60%"><br></html>
  
 
For more information, consult the MIT iGEM 2011 wiki <html><a href="http://2011.igem.org/Team:MIT/Results">here.</a></html>
 
For more information, consult the MIT iGEM 2011 wiki <html><a href="http://2011.igem.org/Team:MIT/Results">here.</a></html>

Revision as of 04:08, 29 September 2011

CI434-VP16 Transactivator MammoBlock

This part encodes a protein that combines the CI434 DNA-binding domain with the VP16 viral transactivation domain. This synthetic transactivator is able to moderately activate expression from minCMV-CI434 promoter variants.

<img src='https://static.igem.org/mediawiki/2011/5/50/CI434_Characterization.jpg' style="width:60%">
</html>

For more information, consult the MIT iGEM 2011 wiki here.


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]